Importantly, the expression of Nrf2 and two target genes (HO-1 and NQO1) is down regulated in KIKO NSCs, respect to the WT NSCs (Figures 1E,F), evidencing a defective antioxidant response in FRDA already at early stages of the disease. This evidence concerns the gene NQO1 and Friedreich ataxia.